Fibroblast growth factor 23: roles in health and disease
about
The FGF23-Klotho axis: endocrine regulation of phosphate homeostasisFGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?FGF23 and Phosphate Wasting DisordersCirculating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in ChineseRegulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literatureIsolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.Selection of a novel FGF23-binding peptide antagonizing the inhibitory effect of FGF23 on phosphate uptake.Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23.Vitamin D safety and requirements.A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatinDiffuse pain, hypophosphatemia, and a subcutaneous nodule.Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemiaAblation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.Can features of phosphate toxicity appear in normophosphatemia?Post-renal transplantation hypophosphatemia.Hungry bone syndrome and normalisation of renal phosphorus threshold after total parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia: a case report.Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.Genetic diseases of renal phosphate handling.Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts.Population pharmacokinetic and pharmacodynamic analyses from a 4-month intradose escalation and its subsequent 12-month dose titration studies for a human monoclonal anti-FGF23 antibody (KRN23) in adults with X-linked hypophosphatemia.Does FGF23 toxicity influence the outcome of chronic kidney disease?Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease.Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.
P2860
Q24625902-E96D19F9-FEA1-4E4B-A526-ACB5C1D1F85DQ24653541-E7DCD7DD-5BAE-470D-A563-8F116E02D5E8Q26851904-983BAA2F-D079-4E95-9404-589025A2168CQ28477784-182C9291-3A37-44D9-8616-E2CB5D3C4170Q28592945-268B2779-A95F-4C6C-875A-1B456F3211DDQ33579283-940434C7-FFFE-4EEA-AB71-5D365CACEC66Q33591785-3ECC809C-2EC5-4E3B-810F-F9781FDBEDEBQ34480642-D84AAB6D-7139-48BF-B934-6B87F43B7570Q35525893-4CDAEE0E-D639-497B-AA50-5807C4BF6854Q35829300-8EEF9485-104A-4719-9937-1C50EF3A618FQ35850965-39868D80-A8A7-4AA1-81D5-C5A86BECBA4EQ35925637-AF1D61F0-D293-4B8F-A3A9-64DAF4C83237Q35967107-764C8459-1324-4893-8633-44CC336359EAQ35983157-4DA7F98B-56D8-4862-B555-BC4E9212688FQ36029918-C90C1525-F9E7-4621-8DC8-7539147F9CB4Q37051668-C9F39B2D-7DAF-437B-BFF2-66F229B129F8Q37210780-8669DF89-6A56-4AF2-9835-CE2598C44E89Q37244863-54FBF8F9-5366-4B72-9A7C-AF9B201E74E0Q37551655-ACEC1BFC-3179-409C-B3C1-66EF996437DEQ37623826-6796371D-BB6D-4EC8-8A24-AAE0DDA63AE1Q37679946-3D207FDD-DA55-47A9-A917-1C47E0423F27Q38244118-1C3689A5-34A4-4590-ADEE-A0ABA7E6694DQ39353783-72682E84-DB74-4FC3-91CD-FE61C7315B2BQ40654330-514134C4-9DAF-4CC1-8964-4CFF4E6FD0C9Q43078080-8AD3A24C-79DF-4351-AFE5-AED393C44493Q46567248-60C845A3-A264-48D7-B690-31970CA1D6E5Q53149178-EA93A373-02B1-4FB4-B2DA-10A0AA40105FQ53455976-41C745B7-3A9C-45C3-AA9B-B5D6836D957B
P2860
Fibroblast growth factor 23: roles in health and disease
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Fibroblast growth factor 23: roles in health and disease
@ast
Fibroblast growth factor 23: roles in health and disease
@en
Fibroblast growth factor 23: roles in health and disease
@nl
type
label
Fibroblast growth factor 23: roles in health and disease
@ast
Fibroblast growth factor 23: roles in health and disease
@en
Fibroblast growth factor 23: roles in health and disease
@nl
prefLabel
Fibroblast growth factor 23: roles in health and disease
@ast
Fibroblast growth factor 23: roles in health and disease
@en
Fibroblast growth factor 23: roles in health and disease
@nl
P356
P1476
Fibroblast growth factor 23: roles in health and disease
@en
P2093
Erik A Imel
P304
P356
10.1681/ASN.2005050573
P407
P577
2005-09-01T00:00:00Z